http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-202128207-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2a9702b29b182a925abbc7e68850894 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 |
filingDate | 2020-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69e2ec0e5b7c33f1c67e1ab194cfff26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2cb8e5bc829a91c6cfae116bebba583 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f881be2b2981e69771c3d789ea631e78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_874c82419abea94939def3e8b7cfee8d |
publicationDate | 2021-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-202128207-A |
titleOfInvention | Use of carnosine for the preparation of drugs for inhibiting the formation of colon cancer induced by azoxymethane (AOM) |
abstract | A use of carnosine for the preparation of a drug that inhibits the generation of colon cancer (Azoxymethane, AOM) induced by azomethane (AOM), which uses L-carnosine as a material to administer an effective amount of carnosine to an individual, and wherein The dosage of 0.85~8.5 g/kg 4 times a week of carnosine concentration in the individual can effectively reduce the number of intestinal tumors, abnormal crypts (Aberrant crypt, AC) and abnormal crypt foci (Aberrant crypt foci, ACF) The formation of colorectal cancer and the expression of genes and proteins of Caudal type homeobox 2, CDX2 and Cytokeratin-20 (Krt20), which are the specific indicators of colon cancer, can effectively inhibit the formation of colon cancer. In the future, natural synthetic carnosine will be used for product development. |
priorityDate | 2020-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 145.